Ambrx Biopharma Cayman, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2020 to Q2 2023

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Ambrx Biopharma Cayman, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2020 to Q2 2023.
  • Ambrx Biopharma Cayman, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2023 was 432M shares, a 59.9% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 432M +162M +59.9% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 386M Mar 31, 2023 10-Q 2023-05-11
Q4 2022 270M +335K +0.12% Dec 31, 2022 10-Q 2023-08-09
Q2 2022 270M Jun 30, 2022 6-K 2022-08-29
Q4 2021 270M +270M +158794% Dec 31, 2021 10-K 2023-03-30
Q4 2020 170K* Dec 31, 2020 20-F 2022-04-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.